代謝型グルタミン酸受容体7の世界市場 2020年

• 英文タイトル：Global Metabotropic Glutamate Receptor 7 Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201105166 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、代謝型グルタミン酸受容体7の世界市場を調査対象にし、代謝型グルタミン酸受容体7の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（JBPOS-0101、PGT-117、ADX-71743、その他）、用途別分析（全般性不安障害、小児けいれん、てんかん重積症、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Addex Therapeutics Ltd、Pragma Therapeutics SAS、Aevi Genomic Medicine Inc、Bio-Pharm Solutions Co Ltd ・メーカー別販売量、売上、市場シェア ・代謝型グルタミン酸受容体7の地域別市場分析 ・代謝型グルタミン酸受容体7の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・代謝型グルタミン酸受容体7のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・代謝型グルタミン酸受容体7のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・代謝型グルタミン酸受容体7の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・代謝型グルタミン酸受容体7の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・代謝型グルタミン酸受容体7の種類別市場規模2015-2020：JBPOS-0101、PGT-117、ADX-71743、その他 ・代謝型グルタミン酸受容体7の用途別市場規模2015-2020：全般性不安障害、小児けいれん、てんかん重積症、その他 ・代謝型グルタミン酸受容体7の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論

Market Overview
The global Metabotropic Glutamate Receptor 7 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Metabotropic Glutamate Receptor 7 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Metabotropic Glutamate Receptor 7 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Metabotropic Glutamate Receptor 7 market has been segmented into
JBPOS-0101
PGT-117
ADX-71743
Others

By Application, Metabotropic Glutamate Receptor 7 has been segmented into:
Generalized Anxiety Disorder
Infantile Spasm
Status Epilepticus
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metabotropic Glutamate Receptor 7 market presented in the report. This section sheds light on the sales growth of different regional and country-level Metabotropic Glutamate Receptor 7 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metabotropic Glutamate Receptor 7 market.

The report offers in-depth assessment of the growth and other aspects of the Metabotropic Glutamate Receptor 7 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Metabotropic Glutamate Receptor 7 Market Share Analysis
Metabotropic Glutamate Receptor 7 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metabotropic Glutamate Receptor 7 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metabotropic Glutamate Receptor 7 sales, revenue and market share for each player covered in this report.

The major players covered in Metabotropic Glutamate Receptor 7 are:
Addex Therapeutics Ltd
Pragma Therapeutics SAS
Aevi Genomic Medicine Inc
Bio-Pharm Solutions Co Ltd

Among other players domestic and global, Metabotropic Glutamate Receptor 7 market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metabotropic Glutamate Receptor 7 product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metabotropic Glutamate Receptor 7, with price, sales, revenue and global market share of Metabotropic Glutamate Receptor 7 in 2018 and 2019.
Chapter 3, the Metabotropic Glutamate Receptor 7 competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metabotropic Glutamate Receptor 7 breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Metabotropic Glutamate Receptor 7 market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Metabotropic Glutamate Receptor 7 sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Metabotropic Glutamate Receptor 7 Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metabotropic Glutamate Receptor 7 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 JBPOS-0101
1.2.3 PGT-117
1.2.4 ADX-71743
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Metabotropic Glutamate Receptor 7 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Generalized Anxiety Disorder
1.3.3 Infantile Spasm
1.3.4 Status Epilepticus
1.3.5 Others
1.4 Overview of Global Metabotropic Glutamate Receptor 7 Market
1.4.1 Global Metabotropic Glutamate Receptor 7 Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Addex Therapeutics Ltd
2.1.1 Addex Therapeutics Ltd Details
2.1.2 Addex Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Addex Therapeutics Ltd SWOT Analysis
2.1.4 Addex Therapeutics Ltd Product and Services
2.1.5 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pragma Therapeutics SAS
2.2.1 Pragma Therapeutics SAS Details
2.2.2 Pragma Therapeutics SAS Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pragma Therapeutics SAS SWOT Analysis
2.2.4 Pragma Therapeutics SAS Product and Services
2.2.5 Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Aevi Genomic Medicine Inc
2.3.1 Aevi Genomic Medicine Inc Details
2.3.2 Aevi Genomic Medicine Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Aevi Genomic Medicine Inc SWOT Analysis
2.3.4 Aevi Genomic Medicine Inc Product and Services
2.3.5 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bio-Pharm Solutions Co Ltd
2.4.1 Bio-Pharm Solutions Co Ltd Details
2.4.2 Bio-Pharm Solutions Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bio-Pharm Solutions Co Ltd SWOT Analysis
2.4.4 Bio-Pharm Solutions Co Ltd Product and Services
2.4.5 Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Metabotropic Glutamate Receptor 7 Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Metabotropic Glutamate Receptor 7 Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Metabotropic Glutamate Receptor 7 Manufacturer Market Share in 2019
3.3.2 Top 6 Metabotropic Glutamate Receptor 7 Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Metabotropic Glutamate Receptor 7 Sales, Revenue and Market Share by Regions
4.1.1 Global Metabotropic Glutamate Receptor 7 Sales and Market Share by Regions (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor 7 Revenue and Market Share by Regions (2015-2020)
4.2 North America Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
4.3 Europe Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
4.5 South America Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Metabotropic Glutamate Receptor 7 Sales, Revenue and Market Share by Country
5.1.1 North America Metabotropic Glutamate Receptor 7 Sales and Market Share by Country (2015-2020)
5.1.2 North America Metabotropic Glutamate Receptor 7 Revenue and Market Share by Country (2015-2020)
5.2 United States Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
5.3 Canada Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
5.4 Mexico Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Metabotropic Glutamate Receptor 7 Sales, Revenue and Market Share by Country
6.1.1 Europe Metabotropic Glutamate Receptor 7 Sales and Market Share by Country (2015-2020)
6.1.2 Europe Metabotropic Glutamate Receptor 7 Revenue and Market Share by Country (2015-2020)
6.2 Germany Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
6.3 UK Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
6.4 France Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
6.5 Russia Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
6.6 Italy Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Metabotropic Glutamate Receptor 7 Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Metabotropic Glutamate Receptor 7 Revenue and Market Share by Regions (2015-2020)
7.2 China Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
7.3 Japan Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
7.4 Korea Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
7.5 India Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
7.7 Australia Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Metabotropic Glutamate Receptor 7 Sales, Revenue and Market Share by Country
8.1.1 South America Metabotropic Glutamate Receptor 7 Sales and Market Share by Country (2015-2020)
8.1.2 South America Metabotropic Glutamate Receptor 7 Revenue and Market Share by Country (2015-2020)
8.2 Brazil Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
8.3 Argentina Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Metabotropic Glutamate Receptor 7 Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Metabotropic Glutamate Receptor 7 Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
9.3 Turkey Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
9.4 Egypt Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
9.5 South Africa Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Metabotropic Glutamate Receptor 7 Sales and Market Share by Type (2015-2020)
10.2 Global Metabotropic Glutamate Receptor 7 Revenue and Market Share by Type (2015-2020)
10.3 Global Metabotropic Glutamate Receptor 7 Price by Type (2015-2020)
11 Global Metabotropic Glutamate Receptor 7 Market Segment by Application
11.1 Global Metabotropic Glutamate Receptor 7 Sales Market Share by Application (2015-2020)
11.2 Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Application (2015-2020)
11.3 Global Metabotropic Glutamate Receptor 7 Price by Application (2015-2020)
12 Market Forecast
12.1 Global Metabotropic Glutamate Receptor 7 Sales, Revenue and Growth Rate (2021-2025)
12.2 Metabotropic Glutamate Receptor 7 Market Forecast by Regions (2021-2025)
12.2.1 North America Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025)
12.2.2 Europe Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025)
12.2.3 Asia-Pacific Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025)
12.2.4 South America Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025)
12.2.5 Middle East & Africa Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025)
12.3 Metabotropic Glutamate Receptor 7 Market Forecast by Type (2021-2025)
12.3.1 Global Metabotropic Glutamate Receptor 7 Sales Forecast by Type (2021-2025)
12.3.2 Global Metabotropic Glutamate Receptor 7 Market Share Forecast by Type (2021-2025)
12.4 Metabotropic Glutamate Receptor 7 Market Forecast by Application (2021-2025)
12.4.1 Global Metabotropic Glutamate Receptor 7 Sales Forecast by Application (2021-2025)
12.4.2 Global Metabotropic Glutamate Receptor 7 Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Metabotropic Glutamate Receptor 7 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metabotropic Glutamate Receptor 7 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metabotropic Glutamate Receptor 7 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Addex Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Major Business
Table 9. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Total Revenue (USD Million) (2018-2019)
Table 10. Addex Therapeutics Ltd SWOT Analysis
Table 11. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Product and Services
Table 12. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pragma Therapeutics SAS Basic Information, Manufacturing Base and Competitors
Table 14. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Major Business
Table 15. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Total Revenue (USD Million) (2018-2019)
Table 16. Pragma Therapeutics SAS SWOT Analysis
Table 17. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Product and Services
Table 18. Pragma Therapeutics SAS Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Aevi Genomic Medicine Inc Basic Information, Manufacturing Base and Competitors
Table 20. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Major Business
Table 21. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Total Revenue (USD Million) (2018-2019)
Table 22. Aevi Genomic Medicine Inc SWOT Analysis
Table 23. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Product and Services
Table 24. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bio-Pharm Solutions Co Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Major Business
Table 27. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Total Revenue (USD Million) (2018-2019)
Table 28. Bio-Pharm Solutions Co Ltd SWOT Analysis
Table 29. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Product and Services
Table 30. Bio-Pharm Solutions Co Ltd Metabotropic Glutamate Receptor 7 Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Global Metabotropic Glutamate Receptor 7 Sales by Manufacturer (2018-2019) (K Pcs)
Table 32. Global Metabotropic Glutamate Receptor 7 Revenue by Manufacturer (2018-2019) (USD Million)
Table 33. Global Metabotropic Glutamate Receptor 7 Sales by Regions (2015-2020) (K Pcs)
Table 34. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Regions (2015-2020)
Table 35. Global Metabotropic Glutamate Receptor 7 Revenue by Regions (2015-2020) (USD Million)
Table 36. North America Metabotropic Glutamate Receptor 7 Sales by Countries (2015-2020) (K Pcs)
Table 37. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Countries (2015-2020)
Table 38. North America Metabotropic Glutamate Receptor 7 Revenue by Countries (2015-2020) (USD Million)
Table 39. North America Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries (2015-2020)
Table 40. Europe Metabotropic Glutamate Receptor 7 Sales by Countries (2015-2020) (K Pcs)
Table 41. Europe Metabotropic Glutamate Receptor 7 Sales Market Share by Countries (2015-2020)
Table 42. Europe Metabotropic Glutamate Receptor 7 Revenue by Countries (2015-2020) (USD Million)
Table 43. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales by Regions (2015-2020) (K Pcs)
Table 44. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Regions (2015-2020)
Table 45. Asia-Pacific Metabotropic Glutamate Receptor 7 Revenue by Regions (2015-2020) (USD Million)
Table 46. South America Metabotropic Glutamate Receptor 7 Sales by Countries (2015-2020) (K Pcs)
Table 47. South America Metabotropic Glutamate Receptor 7 Sales Market Share by Countries (2015-2020)
Table 48. South America Metabotropic Glutamate Receptor 7 Revenue by Countries (2015-2020) (USD Million)
Table 49. South America Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries (2015-2020)
Table 50. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales by Countries (2015-2020) (K Pcs)
Table 51. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Countries (2015-2020)
Table 52. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue by Countries (2015-2020) (USD Million)
Table 53. Middle East & Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries (2015-2020)
Table 54. Global Metabotropic Glutamate Receptor 7 Sales by Type (2015-2020) (K Pcs)
Table 55. Global Metabotropic Glutamate Receptor 7 Sales Share by Type (2015-2020)
Table 56. Global Metabotropic Glutamate Receptor 7 Revenue by Type (2015-2020) (USD Million)
Table 57. Global Metabotropic Glutamate Receptor 7 Revenue Share by Type (2015-2020)
Table 58. Global Metabotropic Glutamate Receptor 7 Sales by Application (2015-2020) (K Pcs)
Table 59. Global Metabotropic Glutamate Receptor 7 Sales Share by Application (2015-2020)
Table 60. Global Metabotropic Glutamate Receptor 7 Sales Forecast by Regions (2021-2025) (K Pcs)
Table 61. Global Metabotropic Glutamate Receptor 7 Market Share Forecast by Regions (2021-2025)
Table 62. Global Metabotropic Glutamate Receptor 7 Sales Forecast by Type (2021-2025) (K Pcs)
Table 63. Global Metabotropic Glutamate Receptor 7 Market Share Forecast by Type (2021-2025)
Table 64. Global Metabotropic Glutamate Receptor 7 Sales Forecast by Application (2021-2025)
Table 65. Global Metabotropic Glutamate Receptor 7 Market Share Forecast by Application (2021-2025)
Table 66. Direct Channel Pros & Cons
Table 67. Indirect Channel Pros & Cons
Table 68. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Metabotropic Glutamate Receptor 7 Picture
Figure 2. Global Sales Market Share of Metabotropic Glutamate Receptor 7 by Type in 2019
Figure 3. JBPOS-0101 Picture
Figure 4. PGT-117 Picture
Figure 5. ADX-71743 Picture
Figure 6. Others Picture
Figure 7. Metabotropic Glutamate Receptor 7 Sales Market Share by Application in 2018
Figure 8. Generalized Anxiety Disorder Picture
Figure 9. Infantile Spasm Picture
Figure 10. Status Epilepticus Picture
Figure 11. Others Picture
Figure 12. Global Metabotropic Glutamate Receptor 7 Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Metabotropic Glutamate Receptor 7 Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Metabotropic Glutamate Receptor 7 Sales Market Share by Manufacturer in 2019
Figure 33. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Metabotropic Glutamate Receptor 7 Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Metabotropic Glutamate Receptor 7 Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 38. Global Metabotropic Glutamate Receptor 7 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Regions (2015-2020)
Figure 40. Global Metabotropic Glutamate Receptor 7 Revenue Market Share by Regions in 2018
Figure 41. North America Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
Figure 42. Europe Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
Figure 44. South America Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020)
Figure 46. North America Metabotropic Glutamate Receptor 7 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Countries (2015-2020)
Figure 48. North America Metabotropic Glutamate Receptor 7 Sales Market Share by Countries in 2018
Figure 49. North America Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries in 2018
Figure 51. United States Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Canada Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 53. Mexico Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Europe Metabotropic Glutamate Receptor 7 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries in 2019
Figure 57. Germany Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. UK Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. France Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Russia Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Asia-Pacific Metabotropic Glutamate Receptor 7 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Metabotropic Glutamate Receptor 7 Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Metabotropic Glutamate Receptor 7 Revenue Market Share by Regions 2019
Figure 65. China Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Korea Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. India Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Southeast Asia Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. South America Metabotropic Glutamate Receptor 7 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Metabotropic Glutamate Receptor 7 Sales Market Share by Countries in 2019
Figure 72. South America Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries in 2019
Figure 73. Brazil Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 74. Argentina Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 75. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Metabotropic Glutamate Receptor 7 Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Metabotropic Glutamate Receptor 7 Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. Egypt Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Turkey Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. South Africa Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Global Metabotropic Glutamate Receptor 7 Sales and Growth Rate (2021-2025) (K Pcs)
Figure 84. Global Metabotropic Glutamate Receptor 7 Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025) (K Pcs)
Figure 86. Europe Sales Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025) (K Pcs)
Figure 87. Asia-Pacific Sales Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025) (K Pcs)
Figure 88. South America Sales Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025) (K Pcs)
Figure 89. Middle East & Africa Sales Metabotropic Glutamate Receptor 7 Market Forecast (2021-2025) (K Pcs)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel

---